PT - JOURNAL ARTICLE AU - Alavi, Arash AU - Bogu, Gireesh K AU - Wang, Meng AU - Rangan, Ekanath Srihari AU - Brooks, Andrew W AU - Wang, Qiwen AU - Higgs, Emily AU - Celli, Alessandra AU - Mishra, Tejaswini AU - Metwally, Ahmed A. AU - Cha, Kexin AU - Knowles, Peter AU - Alavi, Amir A AU - Bhasin, Rajat AU - Panchamukhi, Shrinivas AU - Celis, Diego AU - Aditya, Tagore AU - Honkala, Alexander AU - Rolnik, Benjamin AU - Hunting, Erika AU - Dagan-Rosenfeld, Orit AU - Chauhan, Arshdeep AU - Li, Jessi W AU - Li, Xiao AU - Bahmani, Amir AU - Snyder, Michael P TI - Real-time Alerting System for COVID-19 Using Wearable Data AID - 10.1101/2021.06.13.21258795 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.13.21258795 4099 - http://medrxiv.org/content/early/2021/06/21/2021.06.13.21258795.short 4100 - http://medrxiv.org/content/early/2021/06/21/2021.06.13.21258795.full AB - Early detection of infectious disease is crucial for reducing transmission and facilitating early intervention. We built a real-time smartwatch-based alerting system for the detection of aberrant physiological and activity signals (e.g. resting heart rate, steps) associated with early infection onset at the individual level. Upon applying this system to a cohort of 3,246 participants, we found that alerts were generated for pre-symptomatic and asymptomatic COVID-19 infections in 78% of cases, and pre-symptomatic signals were observed a median of three days prior to symptom onset. Furthermore, by examining over 100,000 survey annotations, we found that other respiratory infections as well as events not associated with COVID-19 (e.g. stress, alcohol consumption, travel) could trigger alerts, albeit at a lower mean period (1.9 days) than those observed in the COVID-19 cases (4.3 days). Thus this system has potential both for advanced warning of COVID-19 as well as a general system for measuring health via detection of physiological shifts from personal baselines. The system is open-source and scalable to millions of users, offering a personal health monitoring system that can operate in real time on a global scale.Competing Interest StatementMPS is cofounder and a member of the scientific advisory board of Personalis, Qbio, January, SensOmics, Protos, Mirvie, Oralome. He is on the scientific advisory board of Danaher, Genapsys, and Jupiter.Funding StatementThis work was supported by NIH grants (1R01NR02010501 and 1S10OD023452-01) and gifts from the Flu Lab, as well as departmental funding from the Stanford Genetics department. This study was supported by the Amazon Web Services Diagnostic Development Initiative. The Google Cloud Platform costs were covered by Google for Education academic research and COVID-19 grant awards. We acknowledge the Stanford Genetics Bioinformatics Service Center (GBSC) for providing the gateway to the SCG cluster, Google Cloud Platform and Amazon Web Services for this research. The Stanford REDCap platform (http://redcap.stanford.edu) was developed and operated by the Stanford Medicine Research IT team. The REDCap platform services at Stanford are subsidized by a) Stanford School of Medicine Research Office, and b) the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through grant UL1 TR001085.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:3,246 adult individuals of 18 to 80 years of age were recruited for this study under protocol number 57022 approved by the Stanford University Institutional Review Board. Participants were invited by social media, news, and outreach to participants in previous studies. Participants registered using the REDCap survey system, and were then asked to install the study app called MyPHD (available for iOS and Android devices).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified raw heart rate and steps data used in this study can be downloaded from the following publicly available link: https://storage.googleapis.com/gbsc-gcp-project-ipop_public/COVID-19-Phase2/COVID-19-Phase2-Wearables.zip All data will be made publicly available upon manuscript acceptance.